Physician profile
Peter R Honig
NPI 1194777466
$139,788.95
in general payments reported to CMS, 2019-2025
77 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $15K · 2021: $8,881 · 2022: $11K · 2023: $35K · 2024: $28K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Consulting Fee: $19K · Food and Beverage: $18K · Travel and Lodging: $7,501 · Education: $60.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,875.00 |
| Consulting Fee | $18,802.00 |
| Food and Beverage | $17,818.23 |
| Travel and Lodging | $7,501.48 |
| Education | $60.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $70,628.45 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $15,581.42 | 2019-2025 | |
| Abbvie INC. | $8,793.13 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $8,322.67 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $4,035.94 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Ab | $3,261.90 | 2020 | |
| Allergan, INC. | $2,570.22 | 2019-2020 | |
| Biogen, INC. | $2,512.70 | 2021-2025 | |
| Daiichi Sankyo INC. | $1,801.92 | 2021-2022 | |
| Glaxosmithkline, LLC. | $1,709.44 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $1,419.41 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,396.87 | 2019-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $1,354.94 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Astrazeneca Uk Limited | $1,020.00 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,011.29 | 2019-2025 | Xifaxan |
Show all 77 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $974.55 | 2019-2025 | |
| Amgen INC. | $923.46 | 2019-2025 | Evenity, Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $864.52 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $835.40 | 2019-2025 | Trintellix, Gattex |
| Lundbeck LLC | $767.01 | 2020-2025 | Rexulti |
| Astellas Pharma US INC | $706.77 | 2019-2025 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $638.42 | 2021-2025 | Rexulti |
| Optinose US, INC. | $632.26 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $605.11 | 2019-2025 | Verquvo, Belsomra, Capvaxive |
| Abbott Laboratories | $495.79 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $485.64 | 2022-2025 | Caplyta |
| Amarin Pharma, INC. | $444.49 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $434.68 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Gilead Sciences, INC. | $374.60 | 2019-2025 | |
| Esperion Therapeutics, INC. | $314.36 | 2020-2025 | Nexletol |
| Mallinckrodt Enterprises LLC | $310.30 | 2019 | |
| Mallinckrodt Hospital Products INC. | $296.37 | 2020 | |
| Sumitomo Pharma America, INC. | $293.98 | 2023-2025 | Gemtesa |
| Ironwood Pharmaceuticals, INC | $290.70 | 2019-2024 | Linzess |
| E.R. Squibb & Sons, L.L.C. | $262.11 | 2019-2025 | Eliquis, Camzyos |
| Idorsia Pharmaceuticals US INC | $255.90 | 2022-2024 | Quviviq |
| Corcept Therapeutics | $253.84 | 2022-2025 | Korlym |
| Nestle Healthcare Nutrition INC. | $209.30 | 2021-2023 | |
| Shield Therapeutics INC | $203.72 | 2023-2025 | Accrufer |
| Alkermes, INC. | $199.22 | 2023-2025 | Lybalvi |
| Aimmune Therapeutics, INC. | $174.00 | 2024-2025 | Zenpep |
| Collegium Pharmaceutical, INC. | $169.32 | 2024-2025 | Xtampza, Belbuca |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Axsome Therapeutics, INC. | $148.45 | 2022-2025 | Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $130.70 | 2022 | |
| Eisai INC. | $128.30 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $114.81 | 2019-2023 | Ajovy |
| Regeneron Healthcare Solutions, INC. | $112.83 | 2019 | |
| Ibsa Pharma INC. | $104.74 | 2022-2025 | Licart, Tirosint, Flector |
| Hikma Pharmaceuticals USA | $98.07 | 2019-2023 | Kloxxado |
| Verona Pharma, INC. | $93.18 | 2025 | Ohtuvayre |
| Xeris Pharmaceuticals, INC. | $89.17 | 2022-2024 | Gvoke Hypopen |
| Sanofi Pasteur INC. | $71.17 | 2023-2024 | |
| Horizon Therapeutics Plc | $69.48 | 2020-2022 | |
| Bausch Health US, LLC | $61.27 | 2022 | |
| Ucb, INC. | $61.27 | 2021 | |
| Sunovion Pharmaceuticals INC. | $60.82 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $53.64 | 2021-2023 | Ztlido |
| Arbor Pharmaceuticals, INC. | $46.95 | 2019-2021 | |
| Hologic Sales and Service, LLC | $34.50 | 2024 | Aptima |
| Phathom Pharmaceuticals, INC. | $29.47 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $28.69 | 2025 | Cologuard Collection Kit |
| Stryker Corporation | $26.01 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Viiv Healthcare Company | $24.52 | 2020 | |
| Organon LLC | $21.69 | 2025 | |
| Ardelyx, INC. | $19.94 | 2023 | Ibsrela |
| Vanda Pharmaceuticals INC. | $18.70 | 2025 | Fanapt |
| Azurity Pharmaceuticals, INC. | $18.54 | 2025 | Alvesco |
| Heartflow, INC. | $18.31 | 2022 | |
| Medicomp INC | $17.34 | 2025 | Telepatch Cardiac Monitor |
| Ars Pharmaceuticals Operations, INC. | $16.11 | 2025 | Neffy |
| Eyevance Pharmaceuticals LLC | $15.99 | 2021 | |
| Medtronic, INC. | $15.80 | 2022 | |
| Inari Medical, INC. | $15.04 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Intra-Sana Laboratories | $13.03 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Zyla Life Sciences, INC. | $13.00 | 2019 | |
| Circassia INC. | $11.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Honig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.